Alkermes plc
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
公司地址 1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6
電話號碼 +353 17728000
傳真號碼 --
公司網頁 https://www.alkermes.com
員工數量 2050
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Richard F. Pops Chairman of the Board and Chief Executive Officer 美元 1.25M 25/02/2026
Mr. Joshua Reed Senior Vice President and Chief Financial Officer 美元 181.98K 06/04/2026
Mr. Samuel J. Parisi Interim Principal Accounting Officer; Vice President, Finance of Alkermes, Inc. -- 25/02/2026
Mr. David Joseph Gaffin Executive Vice President, Chief Legal Officer, Secretary and Chief Compliance Officer 美元 684.50K 06/04/2026
Dr. Craig C. Hopkinson, M.D. Executive Vice President, Research and Development and Chief Medical Officer 美元 764.84K 06/04/2026
Mr. Christian Todd Nichols Senior Vice President and Chief Commercial Officer 美元 614.87K 06/04/2026
Mr. Blair C. Jackson Executive Vice President and Chief Operating Officer 美元 736.45K 25/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Brian P. Mckeon Independent Director 06/04/2026
Dr. Cato T. Laurencin,M.D.,PhD Independent Director 06/04/2026
Mr. Richard F. Pops Chairman of the Board and Chief Executive Officer 25/02/2026
Mr. Frank Anders Wilson Lead Independent Director 06/04/2026
Mr. Shane M. Cooke Independent Director; Chairman of the Board of Alkermes Pharma Ireland Limited 06/04/2026
Ms. Nancy S. Lurker Independent Director 06/04/2026
Dr. Nancy L. Snyderman, F.A.C.S.,M.D. Independent Director 06/04/2026
Dr. Richard Brian Gaynor, M.D. Independent Director 06/04/2026
Dr. Christopher I. Wright, M.D.,PhD Independent Director 06/04/2026
 
所屬ETF (更新日期: 02/05/2026 04:42)
代號 名稱 佔比% ▼ 持有日期
CDEICalvert US Large-Cp Div, Eq AndIncETF0.0001%29/04/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF0.0001%29/04/2026
RBProshares Russell 2000 Dynamic BufferETF0.00003%29/04/2026
ABFLAbacus FCF Leaders ETF<0.000001%09/03/2026
ABLGAbacus FCF International Leaders ETF<0.000001%31/03/2026
ABLSAbacus FCF Small Cap Leaders ETF<0.000001%03/09/2025
AVLCAvantis U.S. Large Cap Equity ETF<0.000001%18/09/2025
AVLVAvantis US Large Cap Value ETF<0.000001%18/03/2026
AVMVAvantis U.S. Mid Cap Value ETF<0.000001%27/09/2025
BMEBlackRock Health Sciences<0.000001%31/12/2025
BMEDiShares Health Innovation Active ETF<0.000001%19/03/2026
BTALAGF U.S. Market Neutral Anti-Beta<0.000001%01/12/2025
ESUMEventide US Market ETF<0.000001%31/07/2025
FEACFidelity Enhanced U.S. All-Cap Eq ETF<0.000001%25/02/2026
FSCSFirst Trust SMID Capital Strength ETF<0.000001%19/10/2025
FSGSFirst Trust SMID Growth Strength ETF<0.000001%19/04/2026
FTLSFirst Trust Long/Short Equity ETF<0.000001%02/12/2025
HQHabrdn Healthcare Investors<0.000001%31/10/2025
HQLabrdn Life Sciences Investors<0.000001%31/10/2025
IJSiShares S&P Small-Cap 600 Value ETF<0.000001%06/03/2026
  1    2    3    4    5    6    7   8    9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.